MedEsthetics
JUNE 10, 2024
93% of readers are interested in novel advances in AI imaging for skin cancer detection and tracking! Here are three AI imaging advances for skin cancer detection and tracking.
Lab Muffin Beauty Science
JUNE 10, 2024
The La Roche-Posay UVMune 400 range has been super hyped up because it contains a brand new sunscreen ingredient: Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (MCE), or Mexoryl 400. It’s currently exclusive to L’Oreal, and was developed in conjunction with BASF. I’ve mentioned in passing that I don’t think it’s as much of a game changing “must have” for everyone that some people have.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dermatology Times
JUNE 10, 2024
Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries.
AAFE - American Academy of Facial Esthetics
JUNE 10, 2024
If you have a tuition voucher from a laser company, please call 800.952.0521 to register for this course.
Dermatology Times
JUNE 10, 2024
David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.
Alison Bladh
JUNE 10, 2024
Greek Yogurt Chicken Salad Looking for a light yet satisfying lunch option? This Greek Yogurt Chicken Salad is the perfect blend of creamy and crunchy, packed with protein. It’s an excellent choice for those wanting a nutritious meal without the heaviness. Plus, it’s easy to prepare Ingredients • 2 cups (480 ml) cooked chicken breast, shredded • 1/2 cup (120 ml) Greek yogurt • 1/4 cup (60 ml) mayonnaise (optional for extra creaminess) • 1/2 cup (120 ml) celery, finely chopped • 1/2 cup (120 ml)
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
The Skin Games
JUNE 10, 2024
Watching baseball is one of the joys of my summer, especially cheering for the Phillies! I appreciate that each player on the field is a seasoned athlete, having dedicated years to honing their craft, all in pursuit of their major league ambitions, aiming for the pinnacle of success: the World Series.
Dermatology Times
JUNE 10, 2024
Raj Chovatiya, MD, PhD, discusses how approved AD therapeutics currently address itch and whether any therapeutics will eventually have a remittive effect.
Natural Beauty Med Spa
JUNE 10, 2024
Would you like to achieve a smoother, brighter, and more even complexion? Microneedling is a minimally invasive treatment that may be able to help you reach those goals. It is a wonderful cosmetic option on its own, but did you know that it is even better when it is used alongside PRP? What is microneedling with PRP , and what benefits does it offer?
Dermatology Times
JUNE 10, 2024
Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.
Lipgloss and Aftershave
JUNE 10, 2024
The Ultimate Lash + Brow Profit Guide from elleebana Elevate your salon revenue with the Elleebana Aftercare range! Discover the exclusive allure of the house of Elleebana and boost your salon’s success with our luxurious aftercare collection.
Dermatology Times
JUNE 10, 2024
Catch up on coverage from the last day of the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois.
First Derm
JUNE 10, 2024
Online Dermatologist Atopic Dermatitis vs. Contact Dermatitis: What’s the Difference? Atopic dermatitis (left) and contact dermatitis (right) display different symptoms. Atopic dermatitis features red, inflamed patches with small bumps, while contact dermatitis shows a red, inflamed area with crusting and defined borders What is Dermatitis | Similarities | Differences | Triggers | Causes | Diagnosis | Treatment Options | How to Prevent and Monitor the Progression Key Takeaways Atopic Dermatitis
Dermatology Times
JUNE 10, 2024
The phase 3 IZAR program will evaluate the efficacy and safety of sonelokimab in patients with psoriatic arthritis for a 1 year duration.
US Dermatologt Partners
JUNE 10, 2024
Stillwater, Oklahoma – U.S. Dermatology Partners is pleased to announce the relocation of its Stillwater, Oklahoma , location to a new, expanded office space. U.S. Dermatology Partners Stillwater Announces their Relocation into a New Expanded Office Space The expanded office is located at 1212 W. 12 th Avenue in Stillwater, Oklahoma , and will open on June 10, 2024.
Dermatology Times
JUNE 10, 2024
Phase 3 clinical results showed that the safety and tolerability profiles were consistent with those observed in the original pivotal trials.
Spa Industry Association
JUNE 10, 2024
L+A has created an 8 W eek Summer School Course that includes exclusive access to 13 Webinars and 7 Downloadable Guides / E-books. L+A Summer School is free! This course includes exclusive access to thirteen webinars and seven downloadable guides or ebooks. It’s a fantastic opportunity to invest in yourself through ongoing education. Register once and you’ll receive updates on all the classes and replays.
Dermatology Times
JUNE 10, 2024
Amy Paller, MD, reviews the various types of therapeutics available and coming soon for pediatric atopic dermatitis and how she decides what treatment approach is best for each patient.
Lipgloss and Aftershave
JUNE 10, 2024
You may think it’s too good to be true that a non-surgical treatment that is non-invasive can provide firmness to skin laxity, boost the skin volume, and give it a luminescent glow until you learn about Sesha’s combination of sophisticated ingredients and their P.E.T® Technology Delivery System! Thanks to Sesha for sponsoring this content so that we can educate the L+A community on this incredible treatment.
Dermatology Times
JUNE 10, 2024
The trial reported complete hair regrowth for a number of participants, with 76% of a partial cohort meeting the primary endpoint of 30% improvement.
Beauty Launchpad
JUNE 10, 2024
Get to know Sandrelly Soto (@lelystyles). She is a hairstylist at Theory Salon Mills 50 in Orlando, FL.
Dermatology Times
JUNE 10, 2024
Roflumilast cream 0.15% is being evaluated for patients with mild to moderate atopic dermatitis down to 6 years.
Skin Inc
JUNE 10, 2024
acne treatment, acne education, acne treatments, acne products, spa business, spa business tips, acne business, spa owner
The Dermatology Digest
JUNE 10, 2024
Transplanting healthy skin to diseased areas may be treatment option for epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC), according to a study out of Nagoya University Graduate School of Medicine in Japan. The researchers found that revertant somatic recombination could be used for a pioneering therapy. By making grafts called cultured epidermal autografts (CEAs), which contain genetic mutation corrections that give healthy skin, and grafting these naturally corrected skin cells
Dermatology Times
JUNE 10, 2024
Kristine Kucera, PA-C, MPAS, DHS, discusses prescribing a PDE-4 inhibitor for Mickey Bryson's psoriasis and atopic dermatitis, emphasizing the absence of FDA-approved medications like JAK inhibitors, while Bryson underscores the challenges of daily injections, likening it to insulin use.
The Dermatology Digest
JUNE 10, 2024
MoonLake Immunotherapeutics received positive feedback from the U.S. Food and Drug Administration (FDA) and the E.U. European Medicines Agency (EMA) on its Phase 3 Program for the nanobody sonelokimab in Psoriatic Arthritis (PsA). Sonelokimab (M1095) is an investigational ~40 kDa humanized nanobody consisting of three VHH domains covalently linked by flexible glycine-serine spacers.
The Dermatology Digest
JUNE 10, 2024
The U.S. Food and Drug Administration (FDA) approved Almirall’s recent supplemental New Drug Application (sNDA) to expand the use area of tirbanibulin ( Klisyri) for the treatment of actinic keratosis (AK) on the face or scalp up to 100 cm 2. Klisyri, a microtubule inhibitor ointment, is now approved in a 350 mg package size and is a 5-day topical field treatment for actinic keratosis (AK) of the face or scalp.
The Dermatology Digest
JUNE 10, 2024
Avrom Caplan, MD, an Assistant Professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine in New York City, shares details on the first reported U.S. case of a sexually transmitted form of ringworm caused by Trichophyton mentagrophytes type VII (TMVII) in a man in his 30s who developed the rash on his penis, buttocks, and limbs after returning home to New York City from a trip to England, Greece, and California.
Expert insights. Personalized for you.
146 
Let's personalize your content